Robert Svatek

Professor & Chair · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

Credentials: · · ·

History

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present

University of Texas M D Anderson Cancer Center
2009–2010
University of Texas Health Science Center at Houston
2009
Urology
University of Texas Southwestern Medical Center
2003–2007
General Surgery
University of Texas Southwestern Medical Center
2002–2003
University of Texas Medical Branch at Galveston School of Medicine
1998–2002
Internal Medicine
University of Texas Medical Branch Hospitals
1999–2002

Research

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
The Lancet · 2018 · 629 citations
The economics of bladder cancer: costs and considerations of caring for this disease
Systematic review or meta-analysis · European Urology · 2014 · First of 7 authors · 428 citations
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
The Lancet Oncology · 2021 · 402 citations

Yair Lotan
75 papers
SS
Shahrokhf Shariat
48 papers
Colin Dinney
36 papers
Ashish Kamat
35 papers
SL
Seth Lerner
31 papers
Dharam Kaushik
25 papers
Michael Liss
24 papers · 2 as a resident
DT
Derya Tilki
22 papers
AS
Arthur Sagalowsky
21 papers
Hanzhang Wang
21 papers · 1 as a resident
Eila Skinner
20 papers
Tyler Curiel
18 papers

Grants

eRapa for Bladder Cancer Prevention
National Cancer Institute · R01
Contact PI · $2.3M · University of Texas Hlth Science Center
2020–2027
Improving Immunotherapy in Bladder Cancer by Targeting Immune Dysfunction
National Cancer Institute · K23
Contact PI · $673.9K · University of Texas Hlth Science Center
2014–2018

Clinical trials

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Principal investigator · Active not recruiting · Phase 2
Robert Svatek
2021–2027
S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer
Principal investigator · Active not recruiting · Phase 3
SWOG Cancer Research Network
2017–2026
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
Principal investigator · Completed · Early phase 1
The University of Texas Health Science Center at San Antonio
2016–2021
Intravesical BCG Administration to Patients With Invasive Bladder Cancer
Principal investigator · Terminated
The University of Texas Health Science Center at San Antonio
2013–2019